BioHK2026: Post - Conference Takeaways
BIOHK2026: How AI and Next-Gen Delivery are Redefining China Biotech Value
Last week’s BIOHK2026 Biotech Investment Summit, hosted by Selesta, highlighted pivotal drivers shaping China’s biotech future:
- Chapter 18A Success: The HKEX has firmly established itself as the world’s second-largest biotech fundraising hub, providing pre-revenue companies with accelerated access to global capital.
- AI’s Transformative Role: AI-powered drug discovery and clinical development are reshaping timelines and therapeutic possibilities, with companies like Insilico Medicine leading the way.
- New Delivery Modalities: Innovations in drug delivery, from suprachoroidal injections to protease-activated T-cell engagers, are emerging as key differentiators.
Want to know more? Download the full report to explore detailed insights on Chapter 18A updates, BD trends, and next-gen biotech innovation.
1
Anytime Access
Praesent porttitor, nulla vitae posuere iaculis, arcu nisl dignissim dolor, a pretium mi sem ut ipsum. Fusce fermentum.
2
Add-ons Compatibility
Praesent porttitor, nulla vitae posuere iaculis, arcu nisl dignissim dolor, a pretium mi sem ut ipsum. Fusce